The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21, 1502–1513 (2000).
Thygesen, K. et al. Universal definition of myocardial infarction. Circulation 116, 2634–2653 (2007).
Thygesen, K. et al. Third universal definition of myocardial infarction. Circulation 126, 2020–2035 (2012).
Thygesen, K. et al. Fourth universal definition of myocardial infarction. Circulation 138, e618–e651 (2018).
Gard, A. et al. Diagnosing type 2 myocardial infarction in clinical routine. A validation study. Scand. Cardiovasc. J. 53, 259–265 (2019).
Gregson, J. et al. Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization. J. Am. Coll. Cardiol. 76, 1609–1621 (2020).
Neumann, J. T. et al. Discrimination of patients with type 2 myocardial infarction. Eur. Heart J. 38, 3514–3520 (2017).
Chapman, A. R. et al. High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation 141, 161–171 (2020).
Hammarsten, O., Mair, J., Möckel, M., Lindahl, B. & Jaffe, A. S. Possible mechanisms behind cardiac troponin elevations. Biomarkers 23, 725–734 (2018).
Árnadóttir, A. et al. Temporal release of high-sensitivity cardiac troponin T and I and copeptin after brief induced coronary artery balloon occlusion in humans. Circulation 143, 1095–1104 (2021).
Shah, A. S. et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386, 2481–2488 (2015).
Devereaux, P. J. et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N. Engl. J. Med. 386, 827–836 (2022).
Hinton, J. et al. Incidence and 1-year outcome of periprocedural myocardial infarction following cardiac surgery: are the Universal Definition and Society for Cardiovascular Angiography and Intervention criteria fit for purpose? Eur. J. Cardiothorac. Surg. 62, ezac019 (2022).
Zeitouni, M. et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur. Heart J. 39, 1100–1109 (2018).
Saaby, L. et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am. J. Med. 126, 789–797 (2013).
McCarthy, C. P. et al. Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction. J. Am. Coll. Cardiol. 77, 848–857 (2021).
Eggers, K. M., Baron, T., Chapman, A. R., Gard, A. & Lindahl, B. Management and outcome trends in type 2 myocardial infarction: an investigation from the SWEDEHEART registry. Sci. Rep. 13, 7194 (2023).
Bularga, A. et al. Coronary artery and cardiac disease in patients with type 2 myocardial infarction: a prospective cohort study. Circulation 145, 1188–1200 (2022).
Herrick, J. B. Certain clinical features of sudden obstruction of the coronary arteries. JAMA 59, 2015–2020 (1912).
Chapman, A. R. et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 137, 1236–1245 (2018).
Sepehrvand, N. et al. Alignment of site versus adjudication committee-based diagnosis with patient outcomes: insights from the providing rapid out of hospital acute cardiovascular treatment 3 trial. Clin. Trials 13, 140–148 (2016).
Gard, A., Lindahl, B. & Baron, T. Impact of clinical diagnosis of myocardial infarction in patients with elevated cardiac troponin. Heart https://doi.org/10.1136/heartjnl-2022-322298 (2023).
DeFilippis, A. P. et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation 140, 1661–1678 (2019).
Mueller, C. et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann. Emerg. Med. 68, 76–87 (2016).
Ljung, L. et al. A rule-out strategy based on high-sensitivity troponin and HEART score reduces hospital admissions. Ann. Emerg. Med. 73, 491–499 (2019).
Anand, A. et al. High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial. Circulation 143, 2214–2224 (2021).
Doudesis, D. et al. Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations. Nat. Med. 29, 1201–1210 (2023).
Spitzer, E. et al. Critical appraisal of contemporary clinical endpoint definitions in coronary intervention trials: a guidance document. JACC Cardiovasc. Interv. 12, 805–819 (2019).
de Lemos, J. A., Newby, L. K. & Mills, N. L. A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction. Circulation 140, 1773–1775 (2019).
Lee, K. K. et al. Prevalence, determinants and clinical associations of high-sensitivity cardiac troponin in patients attending emergency departments. Am. J. Med. 132, 110.e8–110.e21 (2019).
Baron, T. et al. Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction. Am. J. Med. 129, 398–406 (2016).
Garcia-Garcia, H. M. et al. Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 consensus document. Circulation 137, 2635–2650 (2018).